









Markets
/
Stocks
/
nasdaq-fonr
/

Fonar Corp

FONR

18.560USD

+0.030+0.16%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

121.59MMarket Cap

16.37P/E TTM



Fonar Corp

18.560

+0.030+0.16%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Fonar Corp

Currency: USD Updated: 2026-02-06

Key Insights

Fonar Corp's fundamentals are relatively very healthy, with industry-average ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 135 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Fonar Corp's Score

Industry at a Glance

Industry Ranking

135 / 205

Overall Ranking

391 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Fonar Corp Highlights

StrengthsRisks

FONAR Corporation is engaged in the research, development, production and marketing of medical scanning equipment, which uses principles of Magnetic Resonance Imaging (MRI) for the detection and diagnosis of human diseases. The Company conducts its business in two segments: medical equipment, and physician management and diagnostic services. Its medical equipment segment is conducted directly through the Company. Its physician management and diagnostic services segment is conducted through its subsidiary, Health Management Corporation of America (HMCA). Its signature product is the FONAR UPRIGHT Multi-Position MRI (STAND-UP MRI). HMCA provides management services, administrative services, billing and collection services, compliance consulting, purchasing, information technology (IT) services, repair, maintenance service, and clerical and other non-medical personnel to medical providers engaged in diagnostic imaging. HMCA owns and operates six diagnostic imaging facilities in Florida.

Overvalued

The company’s latest PE is 16.37, at a high 3-year percentile range.

Held by The Vanguard

Star Investor The Vanguard holds 363.79K shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.27.

Analyst Rating

Based on 0 analysts

Current Rating

Target Price

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Fonar Corp is 8.39, ranking 45 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 26.04M, representing a year-over-year increase of 4.34%, while its net profit experienced a year-over-year increase of 27.87%.

Score

Industry at a Glance

Previous score

8.39

Change



Financials

9.94

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.36

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

8.59

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

8.72

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.35

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Fonar Corp's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Fonar Corp is 6.36, ranking 165 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 16.37, which is 0.92% below the recent high of 16.52 and 51.03% above the recent low of 8.02.

Score

Industry at a Glance

Previous score

6.36

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 135/205

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

No earnings forecast score is currently available for Fonar Corp. The Healthcare Equipment & Supplies industry's average is 7.77.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Fonar Corp is 5.40, ranking 179 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 18.71 and the support level at 18.45, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

5.05

Change

0.35

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(1)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

-0.301

Neutral

RSI(14)

71.726

Buy

STOCH(KDJ)(9,3,3)

23.277

Buy

ATR(14)

0.070

Low Volatility

CCI(14)

-160.120

Sell

Williams %R

73.077

Sell

TRIX(12,20)

0.399

Sell

StochRSI(14)

17.001

Oversold

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

18.568

Sell

MA10

18.607

Sell

MA20

18.617

Sell

MA50

16.733

Buy

MA100

15.976

Buy

MA200

15.326

Buy

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Fonar Corp is 5.00, ranking 113 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 57.41%, representing a quarter-over-quarter decrease of 3.38%. The largest institutional shareholder is The Vanguard, holding a total of 363.79K shares, representing 5.86% of shares outstanding, with 6.69% decrease in holdings.

Score

Industry at a Glance

Previous score

5.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Kayne Anderson Rudnick Investment Management, LLC

536.99K

-1.30%

Money Concepts Capital Corp

483.52K

+4.49%

Dimensional Fund Advisors, L.P.

376.98K

+1.18%

The Vanguard Group, Inc.

Star Investors

388.44K

-0.49%

Renaissance Technologies LLC

Star Investors

308.62K

-2.19%

Damadian (Timothy Raymond)

121.96K

+54.26%

Peapod Lane Capital LLC

113.34K

-20.85%

BlackRock Institutional Trust Company, N.A.

90.75K

+0.83%

Truffle Hound Capital, LLC

90.00K

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Fonar Corp is 3.60, ranking 121 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.99. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Fonar Corp’s latest ESG disclosure is at an average level in the Healthcare Equipment & Supplies industry, showing no material impact on overall risk.